Table of Content

1 Product Definition
1.1 Criteria for Exclusions

2 Scope of the Study
2.1 Key Questions to be Answered

3 Research Methodology
3.1 Criteria for Selection of Countries
3.2 Data Sources

4 Introduction
4.1 Entry of Surgical Robots in the Market

5 North America
5.1 U.S.
5.1.1 Regulatory Scenario in U.S.
5.1.1.1 Food and Drug Administration (FDA) and Classification of Medical Devices
5.1.1.2 Groups Ensuring Regulations and Safety of Surgical Robots
5.1.1.3 Training requirements in the U.S for Performing Robot- Assisted Surgeries (RAS)
5.1.2 Reimbursement Scenario in the U.S.
5.1.2.1 Documentation
5.1.2.2 Coverage for Use of Robotic Technique Within the Policies of Major Private Health Insurance Providers in the U.S.
5.1.3 Conclusion
5.2 Canada
5.2.1 Regulatory Scenario in Canada
5.2.2 Reimbursement Scenario in Canada
5.2.2.1 Key Stakeholders in the Canadian Reimbursement Process
5.2.2.2 Reimbursement for Medical

6 Asia-Pacific
6.1 Japan
6.1.1 Regulatory Scenario in Japan
6.1.1.1 Regulatory Pathway for Medical
6.1.1.2 Structure of Healthcare System in Japan
6.1.2 Reimbursement Scenario in Japan
6.1.2.1 Reimbursment of daVinci Surgical Robotic Systems in Japan
6.2 China
6.2.1 Regulatory Scenario in China
6.2.1.1 Classification of Medical Devices in China
6.2.1.2 Regulatory Changes in China
6.2.1.3 The Market Access Process For Imported Medical Devices
6.2.2 Reimbursement Scenario in China
6.2.2.1 Provincial Reimbursement Issues
6.3 Australia
6.3.1 Regulatory Scenario in Australia
6.3.1.1 Lifecycle of Regulations by TGA
6.3.1.2 Post-market Regulations
6.3.1.3 Adverse Event and Incident Reporting
6.3.2 Reimbursement Scenario in Australia

7 European Union
7.1 Regulatory Scenario in European Union
7.1.1 Changes in Rule
7.1.2 New Rules in the Annexure VIII
7.1.2.1 Expanded Device Definitions Requiring Reexamination of Current Classification of all Devices
7.1.2.2 Quality Management System
7.1.2.3 Technical File
7.1.2.4 Need to Comply with New Identification and Traceability (UDI) Requirements
7.1.2.5 More Emphasis on Post Market Surveillance
7.1.2.6 Role of Internal Audits and Requirement of Audits Strengthened
7.1.2.7 Dedicated Personal for MDR
7.2 Reimbursement Scenario in European Union
7.2.1 France
7.2.2 Germany
7.2.3 U.K.
7.2.3.1 Multiple Technology Appraisal
7.2.3.2 Single Technology Appraisal (STA)
7.2.4 Italy
7.2.5 Spain

List of Table
Table 6.1 The TGA Medical Device Classification System
List of Figures
Figure 3.1 Global Surgical Robotics Market, 2018 - 2029
Figure 3.2 Market Share of Top 10 Countries in the Global Surgical Robotics Market, 2018 and 2029
Figure 5.1 Regulatory Process for Medical Devices in the U.S.
Figure 7.1 MDR Transitional Provisions (EU)
Figure 7.2 Conformity Assessment Routes for Class IIb Medical Devices
Figure 7.3 France Reimbursement System
Figure 7.4 German Reimbursement System
Figure 7.5 Reimbursement System in the U.K.
Figure 7.6 Reimbursement System in Italy